Sirnaomics Ltd
02257
Company Profile
Business description
Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group’s operations and non-current assets are located at the United States of America and the mainland of the People’s Republic of China.
Contact
No.218 Xinghu Street
Unit 415, A4 Building
Suzhou Industrial Park
Suzhou
CHNT: +86 51262956283
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
69
Stocks News & Analysis
stocks
Undervalued ASX share showing progress in global efforts
More clarity on the path forward in the UK.
stocks
Bookworm: Is this the secret to exceptional long-term returns?
Acceptance may be an investor’s best friend.
stocks
Unconventional wisdom: Are dividends the answers?
As investors toil in complexity the obvious solution may be the right one.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,964.20 | 29.90 | 0.33% |
CAC 40 | 7,834.58 | 16.30 | 0.21% |
DAX 40 | 24,217.50 | 78.43 | -0.32% |
Dow JONES (US) | 44,901.92 | 208.01 | 0.47% |
FTSE 100 | 9,120.31 | 18.06 | -0.20% |
HKSE | 25,510.31 | 121.96 | 0.48% |
NASDAQ | 21,108.32 | 50.36 | 0.24% |
Nikkei 225 | 41,042.20 | 414.03 | -1.00% |
NZX 50 Index | 12,910.74 | 57.28 | 0.45% |
S&P 500 | 6,388.64 | 25.29 | 0.40% |
S&P/ASX 200 | 8,698.70 | 31.80 | 0.37% |
SSE Composite Index | 3,594.40 | 0.74 | 0.02% |